Search
Agios Pharmaceuticals Inc
AGIOAdd to Watchlist
34.160USD
+1.080+3.26%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.03BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Agios Pharmaceuticals Inc is 8.00, ranking 165 out of 389 in the Biotechnology & Medical Research industry. The average price target is 32.00, with a high of 48.00 and a low of 20.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
42.143
Target Price
+23.37%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Agios Pharmaceuticals Inc
AGIO
10
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Agios Pharmaceuticals Inc's expected revenue for the next quarter?
Agios Pharmaceuticals Inc's expected revenue is 27.06M.
What is Agios Pharmaceuticals Inc's price target?
Analysts forecast that Agios Pharmaceuticals Inc's price target is USD 32.00, with the highest forecast at USD 48.00 and the lowest forecast at USD 20.00.
How have Agios Pharmaceuticals IncAGIO's recent earnings per share performed?
The market expectation was USD -1.69, while Agios Pharmaceuticals IncAGIO's earnings per share (EPS) for the previous quarter was USD -1.85. EPS for the next quarter is expected at USD -1.67.
What is the analyst rating for Agios Pharmaceuticals Inc?
Based on the ratings of Agios Pharmaceuticals Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
